Skip to main content
. 2021 Aug 5;35(2):213–219. doi: 10.1177/19714009211036695

Table 3.

Clinical outcome in the intra-arterial nimodipine (IAN) group.

IAN, n (%)
mRS 0–2 (30 d) 12 (25%)
mRS 3–5 (30 d) 32 (67%)
mRS 0–2 (6 m) 22 (47%)
mRS 3–5 (6 m) 20 (42%)
Mortality (30 d) 4 (8%)
Mortality (6 m) 6 (13%)

d: days; m: months; mRS: modified Rankin Scale.